Skip Navigation LinksHome > March 2013 - Volume 8 - Issue 2 > Study design issues in evaluating immune biomarkers
Current Opinion in HIV & AIDS:
doi: 10.1097/COH.0b013e32835d3259
NEW ADVANCES IN IMMUNOLOGICAL AND VIROLOGICAL MONITORING: Edited by Alan L. Landay and Tae-Wook Chun

Study design issues in evaluating immune biomarkers

Bosch, Ronald J.a; Zhang, Xinyana; Sandler, Netanya G.b

Collapse Box

Abstract

Purpose of review: The dramatic increase in the number and type of immune biomarkers that can be measured, particularly those assessing immune activation, has led to numerous investigations in HIV-infected individuals to explore pathogenesis and to assess therapeutic interventions that aim to attenuate immune activation. An overview is provided on study designs and related statistical and operational issues relevant to these investigations.

Recent findings: Cohort studies and nested case–control studies within these cohorts have identified multiple biomarkers that are associated with an increased risk of disease. Early-stage clinical trials of therapies to address these risks in HIV-infected individuals with viral suppression on antiretroviral therapy are a substantial focus of current HIV research.

Summary: Appropriate study design is essential in biomarker research.

© 2013 Lippincott Williams & Wilkins, Inc.

Login

Search for Similar Articles
You may search for similar articles that contain these same keywords or you may modify the keyword list to augment your search.